Skip to main content

Table 3 Shows fecal SCFA concentrations (in mmol/g, median and range) and the respective p value (difference between female and male subjects) for each investigated SCFA separately

From: Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?

 

Patients (n = 41)

Controls (n = 35)

All (n = 76)

m

n = 12

f

n = 29

p

m

n = 22

f

n = 13

p

m

n = 34

f

n = 42

p

Acetate mmol/g

51.48 [0.67–121.05]

3.76 [0.07–160.26]

0.357

73.4 [1.04–193.06]

8.02 [0.66–71.22]

0.005

68.89 [0.67–193.06]

6.47 [0.07–160.26]

0.012

Propionate mmol/g

14.25 [0.37–99.47]

1.29 [0.1–43.07]

0.227

21.09 [0.22–87.81]

1.59 [0.17–27.08]

0.004

19.40 [0.22–99.47]

1.44 [0.01–43.07]

0.002

Butyrate mmol/g

9.17 [0.14–39.53]

0.88 [0.02–41.49]

0.127

15.95 [0.05–52.54]

1.89 [0.08–18.98]

0.16

15.63 [0.55–52.54]

1.37 [0.02–41.49]

0.003

IsoButyrate mmol/g

1.9 [0.02–4.23]

0.97 [0.004–6.13]

0.436

2.33 [0.02–11.35]

1.55 [0.01–4.01]

0.243

2.10 [0.02–11.35]

0.88 [0.00–6.13]

0.061

Valerate mmol/g

1.55 [0.01–5.2]

0.96 [0.002–5.64]

0.142

2.07 [0.01–19.76]

0.63 [0.01–3.05]

0.067

1.58 [0.01–19.76]

0.53 [0.00–5.64]

0.004

Isovalerate mmol/g

1.6 [0.02–5.78]

0.099 [0.007–5.49]

0.342

2.25 [0.02–17.03]

2.04 [0.01–5.32]

0.335

1.94 [0.02–17.03]

0.55 [0.01–5.49]

0.068